Overview

Company Profile

MYOS RENS is an emerging BioNutrition and BioTherapeutics  company focused on the discovery, development and commercialization of products that improve muscle health and function essential to the management of sarcopenia, cachexia and degenerative muscle diseases.

View Detailed Stock Data

Stock Snapshot

MYOS Symbol
Nasdaq Market
Market Cap
Price
Change
Volume
View IR Calendar

Events

Digital replay is available through July 31, 2018. The replay may be accessed by dialing 877-660-6853 from the U.S. or 201-612-7415 for international callers, Conference ID# 13679724.

Webcast